VIVEVE MEDICAL, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2013 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Viveve Medical, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2013 to Q3 2022.
  • Viveve Medical, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2022 was $868K, a 20.2% decline year-over-year.
  • Viveve Medical, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2022 was $3.75M, a 10.1% increase year-over-year.
  • Viveve Medical, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.78M, a 42.6% increase from 2020.
  • Viveve Medical, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $2.65M, a 10.5% increase from 2019.
  • Viveve Medical, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $2.4M, a 20.9% decline from 2018.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $3.75M $868K -$220K -20.2% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $3.97M $909K +$42K +4.84% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $3.93M $960K +$150K +18.5% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $3.78M $1.01M +$372K +57.9% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-17
Q3 2021 $3.41M $1.09M +$446K +69.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $2.96M $867K +$210K +32% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $2.75M $810K +$100K +14.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $2.65M $642K -$123K -16.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 $2.77M $642K +$124K +23.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $2.65M $657K +$36K +5.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $2.61M $710K +$214K +43.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $2.4M $765K +$23K +3.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 $2.38M $518K -$247K -32.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $2.62M $621K -$154K -19.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $2.78M $496K -$257K -34.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $3.04M $742K +$184K +33% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-19
Q3 2018 $2.85M $765K +$278K +57.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $2.57M $775K +$320K +70.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $2.25M $753K +$381K +102% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $1.87M $558K +$200K +55.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 $1.67M $487K +$215K +79% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $1.46M $455K +$253K +125% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $1.2M $372K +$184K +97.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $1.02M $358K +$283K +377% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 $737K $272K +$217K +395% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $520K $202K +$154K +321% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $366K $188K +$146K +348% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 $220K $75K +$34K +82.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-16
Q3 2015 $186K $55K -$58K -51.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $244K $48K +$31K +182% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $213K $42K +$29K +223% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $184K $41K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-24
Q3 2014 $113K +$96.7K +594% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 $17K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $13K +$1K +8.33% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q3 2013 $16.3K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q1 2013 $12K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.